Call for paper

Journal of Pharmacoeconomics and Pharmaceutical Management (JPPM) is an international peer-reviewed journal, which publishes original

 research articles, reviews, letters and editorials on all fields of Pharmacoeconomics, and pharmaceutical management. It is dedicated to the clear communication of policy and economic issues related to pharmaceutical system, pharmaceutical industries, patient services and rational use of medicines.

JPPM calls Scholars, Academicians, Scientists, Industrial professionals and Researchers from all over the world to submit their original articles for inclusion in our upcoming issue. All submissions will be reviewed and evaluated based on originality, technical research, and relevance to journal contributions. The areas of interest include:

  • All types of economic evaluation studies such as cost effectiveness analysis, cost utility analysis, cost benefit analysis;
  • Economic analysis of Pharmaceutical policies;
  • Cost of illness studies;
  • Evaluation of pharmacoeconomic methodologies;
  • Analysis of pharmaceutical pricing policies;
  • Analysis of pharmaceutical reimbursement policies;
  • Outcomes research and quality-of-life assessments;
  • Prescribing decisions;
  • Analysis of pharmaceutical markets;
  • Pharmaceutical Industry Analysis (Regulation, Innovation, and other related issues).

We welcome theoretical, technical, research, as well as empirical papers from all areas of research in the area of Pharmacoeconomics & Pharmaceutical Management trends. All the accepted articles will be published in the upcoming issue of the journal. Online submission is available here. Please consider authors guidelines before.

  • Type of papers to publish: Research Paper, Survey Paper, Informative Article, Case Studies, Review Papers, Comparative Studies, Dissertation Chapters, Synopsis, M.Tech / M.E / PhD Thesis, and Policy brief
  • Accepted Language: English
  • Payment for manuscripts review and publish: Not-needed (Yet)
  • For more information and any question contact us.